Are blood eosinophils a prime-time biomarker for COPD management decisions?

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD (homepage on the Internet)Global Initiative for Chronic Obstructive Lung Disease (GOLD)2018 Available from: http://goldcopd.orgAccessed May 5, 2018
   Google Scholar
• CalverleyPMTetzlaffKVogelmeierCEosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201719691219122128306321
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDThorax201671211812526585525
   PubMed Web of Science ®Google Scholar
• PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
   PubMed Web of Science ®Google Scholar
• PapiAKostikasKWedzichaJADual bronchodilation response by exacerbation history and eosinophilia in the FLAME studyAm J Respir Crit Care Med Epub2017113
   Web of Science ®Google Scholar
• WedzichaJABanerjiDChapmanKRFLAME InvestigatorsIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWISDOM InvestigatorsWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ200032072451297130310807619
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• BafadhelMPetersonSDe BlasMAPredictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trialsLancet Respir Med20186211712629331313
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• NegewoNAMcDonaldVMBainesKJPeripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPDInt J Chron Obstruct Pulmon Dis2016111495150427445469
   PubMed Web of Science ®Google Scholar
• TuratoGSemenzatoUBazzanEBlood eosinophilia does not reflect tissue eosinophils nor worsen clinical outcomes in COPDAm J Respir Crit Care Med Epub20171016
   Google Scholar
• Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
   PubMed Web of Science ®Google Scholar
• HoJHeWChanMTVEosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPDSci Rep2017711345129044160
   PubMed Web of Science ®Google Scholar
• CasanovaCCelliBRde-TorresJPPrevalence of persistent blood eosinophilia: relation to outcomes in patients with COPDEur Respir J2017505 pii170116229167301
   PubMed Web of Science ®Google Scholar
• SinghDKolsumUBrightlingCELocantoreNAgustiATal-SingerRECLIPSE InvestigatorsEosinophilic inflammation in COPD: prevalence and clinical characteristicsEur Respir J20144461697170025323230
   PubMed Web of Science ®Google Scholar
• ZysmanMDesleeGCaillaudDRelationship between blood eosinophils, clinical characteristics, and mortality in patients with COPDInt J Chron Obstruct Pulmon Dis2017121819182428694695
   PubMed Web of Science ®Google Scholar
• OshagbemiOABurdenAMBraekenDCWStability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline countsAm J Respir Crit Care Med2017195101402140428165763
   PubMed Web of Science ®Google Scholar
• SennelsHPJørgensenHLHansenALGoetzeJPFahrenkrugJDiurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variationsScand J Clin Lab Invest201171753254121988588
   PubMed Web of Science ®Google Scholar
• IqbalABarnesNCBrooksJIs blood eosinophil count a predictor of response to bronchodilators in chronic obstructive pulmonary disease? Results from post hoc subgroup analysesClin Drug Investig20153510685688
   PubMed Web of Science ®Google Scholar
• KlionADEosinophilia: a pragmatic approach to diagnosis and treatmentHematology Am Soc Hematol Educ Program20152015929726637706
   PubMed Web of Science ®Google Scholar
• NutmanTBEvaluation and differential diagnosis of marked, persistent eosinophiliaImmunol Allergy Clin North Am200727352954917868863
   PubMed Web of Science ®Google Scholar
• TsiligianniIGKosmasEVan der MolenTTzanakisNManaging comorbidity in COPD: a difficult taskCurr Drug Targets201314215817623256716
   PubMed Web of Science ®Google Scholar
• Al-GwaizLABabayHHThe diagnostic value of absolute neutrophil count, band count and morphologic changes of neutrophils in predicting bacterial infectionsMed Princ Pract200716534434717709921
   PubMed Web of Science ®Google Scholar